Vincerx Pharma Inc (NASDAQ: VINC) started the day on Wednesday, with a price decrease of -5.66% at $1.00, before settling in for the price of $1.06 at the close. Taking a more long-term approach, VINC posted a 52-week range of $0.61-$9.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -193.22%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 45.77%. This publicly-traded company’s shares outstanding now amounts to $21.41 million, simultaneously with a float of $13.47 million. The organization now has a market capitalization sitting at $21.41 million. At the time of writing, stock’s 50-day Moving Average stood at $4.1286, while the 200-day Moving Average is $1.7518.
Vincerx Pharma Inc (VINC) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Vincerx Pharma Inc’s current insider ownership accounts for 37.11%, in contrast to 45.80% institutional ownership. According to the most recent insider trade that took place on Aug 11 ’23, this organization’s insider bought 10,500 shares at the rate of 0.95, making the entire transaction reach 9,968 in total value, affecting insider ownership by 30,280. Preceding that transaction, on Aug 10 ’23, Company’s insider bought 5,400 for 0.96, making the whole transaction’s value amount to 5,167. This particular insider is now the holder of 96,060 in total.
Vincerx Pharma Inc (VINC) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported -$0.23 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.37) by $0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
Vincerx Pharma Inc’s EPS increase for this current 12-month fiscal period is 45.77% and is forecasted to reach -0.94 in the upcoming year.
Vincerx Pharma Inc (NASDAQ: VINC) Trading Performance Indicators
Let’s observe the current performance indicators for Vincerx Pharma Inc (VINC). It’s Quick Ratio in the last reported quarter now stands at 2.63. The Stock has managed to achieve an average true range (ATR) of 1.15.
In the same vein, VINC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.89, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.94 at the market close of one year from today.
Technical Analysis of Vincerx Pharma Inc (VINC)
If we take a close look at the recent performances of Vincerx Pharma Inc (NASDAQ: VINC), its last 5-days Average volume was 4.56 million that shows progress from its year to date volume of 1.33 million. During the previous 9 days, stock’s Stochastic %D was recorded 3.04% While, its Average True Range was 1.2339.
Raw Stochastic average of Vincerx Pharma Inc (VINC) in the period of the previous 100 days is set at 4.45%, which indicates a major rise in contrast to 0.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 622.32% that was higher than 292.32% volatility it exhibited in the past 100-days period.
